잠시만 기다려 주세요. 로딩중입니다.

Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex

Experimental & Molecular Medicine 2020년 52권 2호 p.3 ~ 3
 ( Jung Youn-Sang ) - University of Texas MD Anderson Cancer Center Department of Experimental Radiation Oncology

 ( Park Jae-Il ) - University of Texas MD Anderson Cancer Center Department of Experimental Radiation Oncology

Abstract


Wnt/β-catenin signaling is implicated in many physiological processes, including development, tissue homeostasis, and tissue regeneration. In human cancers, Wnt/β-catenin signaling is highly activated, which has led to the development of various Wnt signaling inhibitors for cancer therapies. Nonetheless, the blockade of Wnt signaling causes side effects such as impairment of tissue homeostasis and regeneration. Recently, several studies have identified cancer-specific Wnt signaling regulators. In this review, we discuss the Wnt inhibitors currently being used in clinical trials and suggest how additional cancer-specific regulators could be utilized to treat Wnt signaling-associated cancer.

키워드

Cancer; Drug discovery
원문 및 링크아웃 정보
 
등재저널 정보
SCI(E)
MEDLINE
KCI
KoreaMed
KAMS